Navigation Links
OpGen recruits CEO to further gene-mapping business

Madison, Wis. The biotechnology firm OpGen hopes its new CEO will draw investment to its work in gene mapping, the company said on Monday. R.H. Joseph Shaw is the former CEO of medical firms Quantech and Cathra International.

I think Joe Shaw comes to OpGen with a good history of raising serious funds, and we hope he continues to do the same here, said Life Science Insights. OpGens technology may help identify the genes that result in the variability of patients response to therapy. This information may lead to better and......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 11/29/04


Related biology technology :

1. OpGen layoffs precede another funding round
2. OpGen forges agreement with Japanese importer
3. OpGen completes $5 million investment round
4. OpGen adds Thomas Pyle and James Ogle to board of directors
5. OpGen joins UW, Henry Ford Heath in Improving Brain Tumor Treatment
6. OpGen Creates Map of Worlds Most Lethal Fungus
7. OpGen Database Helps to Reduce Bioterrorist Threat
8. Better collaboration urged to further Wisconsin biotech
9. Johnson Controls jumping further into hybrid-vehicle battery world
10. While schools combat low tech enrollment, are businesses contributing to IT workforce woes?
11. CIOs focus on the business case while facing authority erosion
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):